Merck KGaA‍‍‌‍‌‌‌‌‌‌‍‌‍‌‍‍

German pharmaceutical company

Tracked German pharmaceutical company · 1 documented connection

Facts on record4

Connections mapped1

Sources cited7

View on Graph → Export CSV ← Entity Directory

Stated vs Revealed

No documented contradictions on file.

Connection Map

Key Connections

← Entity #17

partner

Joint partnership through EMD Digital for Syntropy cancer research platform in 2020

Facts (4)

Data Freshness

Fresh Last update: 14d ago · Avg age: 543d

Confidence Tiers: Primary Source — cross-referenced government/corporate filings Pending Review — sourced but not independently verified AI Inference — analytical hypothesis from cross-referencing

Raw Filing Records (1) — unsourced metadata

Pending Review Merck KGaA filed filing with the SEC ‍‍‌‍‌‌‌‌‌‌‍‌‍‌‍‍on 2023-01-27. Accession number: N/A.

Date: 2023-01-27 Added: 08 Apr 2026

All Connections (1)

← Entity #17

partner confirmed

Joint partnership through EMD Digital for Syntropy cancer research platform in 2020

Sources (7)

2026 UNVERIFIED Research: Merck KGaA — Lobbying disclosures (no results) government_disclosure Processed

2026 UNVERIFIED Research: Merck KGaA — Corporate registrations (no results) government_disclosure Processed

2026 UNVERIFIED Research: Merck KGaA — USASpending contracts (no results) contract Processed

2022-01-24 SEC FILING SEC EDGAR: filing — Merck KGaA (2022-01-24) sec_filing Processed

2021-01-08 SEC FILING SEC EDGAR: filing — Merck KGaA (2021-01-08) sec_filing Processed

2024-02-14 SEC FILING SEC EDGAR: filing — Merck KGaA (2024-02-14) sec_filing Processed

2023-01-27 SEC FILING SEC EDGAR: filing — Merck KGaA (2023-01-27) sec_filing Processed